World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Israel
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
104
Citations
38326
World Ranking
1258
National Ranking
9

Alexander Levitzki publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Alexander Levitzki sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 394 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Alexander Levitzki D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Alexander Levitzki sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 104 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Israel Leader Award
  • 2025 - Research.com Biology and Biochemistry in Israel Leader Award

Overview

Alexander Levitzki is affiliated with the Hebrew University of Jerusalem in Israel. Their research primarily focuses on the fields of medicine and biochemistry, genetics, and molecular biology, with notable contributions to oncology, molecular biology, cancer research, radiology, nuclear medicine and imaging, and pulmonary and respiratory medicine.

The scientist's work centers around key topics including cancer immunotherapy and biomarkers, RNA modifications and cancer, cancer therapeutics and mechanisms, lung cancer treatments and mutations, cancer in relation to hypoxia and metabolism, cancer involving lipids and metabolism, and research on monoclonal and polyclonal antibodies.

Alexander Levitzki has published papers in venues such as Regular and Young Investigator Award Abstracts, Cancer Research, and bioRxiv (Cold Spring Harbor Laboratory). Their recent papers include:

  • "1170 EGFR-Ta:RNA: multimodal mechanism of action potentiates immune checkpoint inhibitor activity" (2022, Regular and Young Investigator Award Abstracts)
  • "Abstract 5799: Novel nanoparticle technology targets the delivery of polyIC to EGFR overexpressing cancers and induces a multimodal anti-tumor response" (2024, Cancer Research)
  • "1026 Novel targeted nanoparticles induce a multi-modal anti-tumor response in EGFR-overexpressing cancers" (2024, Regular and Young Investigator Award Abstracts)
  • "EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFR" (2025, bioRxiv [Cold Spring Harbor Laboratory])

Their research involves collaborative work with frequent co-authors including Alexei Shir, Maya Zigler, Babette Schade, Derrick Broka, and Caroline De Feyter.

Best Publications

  • Tyrosine kinase inhibition: an approach to drug development

    Alexander Levitzki;Aviv Gazit

  • Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

    Robyn Catlett-Falcone;Terry H Landowski;Marc M Oshiro;James Turkson

  • Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

    N Meydan;T Grunberger;H Dadi;M Shahar

  • Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

    Roy Garcia;Tammy L Bowman;Guilian Niu;Hua Yu

  • EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

    B. Margolis;S.G. Rhee;S. Felder;M. Mervic

  • Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.

    Aviv Gazit;Pnina Yaish;Chaim Gilon;Alexander Levitzki

  • Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase Inhibitors

    Pnina Yaish;Aviv Gazit;Chaim Gilon;Alexander Levitzki

  • ROS, stress-activated kinases and stress signaling in cancer.

    Moran Benhar;David Engelberg;Alexander Levitzki

  • Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones.

    Peter J. A. Davies;Dana R. Davies;Alexander Levitzki;Alexander Levitzki;Frederick R. Maxfield

  • NEGATIVE COOPERATIVITY IN REGULATORY ENZYMES

    Alexander Levitzki;D. E. Koshland

  • Crystal Structure of Hck in Complex with a Src Family–Selective Tyrosine Kinase Inhibitor

    Thomas Schindler;Frank Sicheri;Alexander Pico;Aviv Gazit

  • Mode of coupling between the beta-adrenergic receptor and adenylate cyclase in turkey erythrocytes.

    Aviva M. Tolkovsky;Alexander Levitzki

  • Enhanced ROS Production in Oncogenically Transformed Cells Potentiates c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Activation and Sensitization to Genotoxic Stress

    Moran Benhar;Idan Dalyot;David Engelberg;Alexander Levitzki

  • Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.

    M. Nagane;A. Levitzki;A. Gazit;W. K. Cavenee

  • Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors

    Abraham Novogrodsky;Alexey Vanichkin;Miriam Patya;Aviv Gazit

  • Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction.

    Alexander Levitzki

  • Metal-binding sites of concanavalin A and their role in the binding of α-methyl d-glucopyranoside

    A. Joseph Kalb;Alexander Levitzki

  • The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions.

    T Volberg;Y Zick;R Dror;I Sabanay

  • From epinephrine to cyclic AMP.

    Alexander Levitzki

  • Epidermal-growth-factor-dependent activation of the src-family kinases.

    Nir Osherov;Alexander Levitzki

Frequent Co-Authors

Chaim Gilon
Chaim Gilon Hebrew University of Jerusalem
Michael L. Steer
Michael L. Steer Harvard University
Daphne Atlas
Daphne Atlas Hebrew University of Jerusalem
Michael Chorev
Michael Chorev Harvard University
Yoav I. Henis
Yoav I. Henis Tel Aviv University
Antony W. Burgess
Antony W. Burgess Walter and Eliza Hall Institute of Medical Research
Daniel E. Koshland
Daniel E. Koshland University of California, Berkeley
Johannes Waltenberger
Johannes Waltenberger University of Münster
Giora Simchen
Giora Simchen Hebrew University of Jerusalem
Richard Jove
Richard Jove Nova Southeastern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Biology or Biochemistry opens doors to diverse fields—especially as healthcare, nutrition, and research expand. Many students and professionals are turning to online education for its flexibility and variety. For example, those interested in dietetics or wellness might explore an online nutritionist degree, which teaches the fundamentals of nutritional science and its applications in public health and clinical settings.

For aspiring healthcare leaders, a cahme-accredited online mha programs list ensures students receive quality management training, preparing them for administrative roles in hospitals and health systems. Nursing professionals seeking advanced practice may opt for msn to dnp online no clinicals degrees, which focus on leadership, policy, and evidence-based practice, often without traditional clinical requirements.

For those driven toward high-level administration, the best doctorate of healthcare administration programs can prepare graduates for executive roles in healthcare organizations. Each pathway can complement a background in Biology or Biochemistry, allowing graduates to impact health, research, and policy in innovative ways.

Best Scientists Citing Alexander Levitzki

Trending Scientists

Recently Published Articles